Clinical Trial Search

Primary: Percentage of Participants With Adverse Events — 100 percentage of participants

Primary: Number of Participants From Each Arm Who Received Influenza Vaccine — 3; 8 Participants

Primary: Number of Participants From Each Arm Who Received Influenza Vaccine — 0; 17 Participants

Primary: Number of Participants Who Received Influenza Vaccine — 1; 7 Participants

Primary: Quality of Life in Chronic Rhinosinusitis Patients — 23; 21 Units on a scale

Primary: Frequency of HSV-2 Total Shedding From the Genital Tract as Measured by PCR, Calculated Using a Per-day Shedding Rate in Participants Treated With Suppressive Acyclovir…

Primary: Number of Participants Who Received Influenza Vaccine — 5; 5; 6; 3 Participants

Primary: Number of Participants Who Received Influenza Vaccine — 14; 38; 36 Participants

Primary: Area Under the Curve of DOTAREM in Plasma — 1591.1 hour.µmol/L

Primary: Neoplasm Miss Rate — 12.6; 12.1 Miss rate percentage

Primary: Percentage of Subjects Rating Each Device as "Easy/Very Easy to Use" Based on User Trial Questionnaire (UTQ) at Week 4 — 34.8; 50.0; 39.1; 30.0 percentage of subjects

Primary: Mean Change in Haemoglobin Concentration. — 1.22; 1.30 g/dl — p=0.23

Primary: Insulin Sensitivity — 6.66; 5.12; 11.37; 12.93 mg/kg fat free mass/min

Primary: Y-BOCS Scores at 1st and Last Visit — 27.45; 20.45 units on a scale

Primary: Quality of Postoperative Recovery Assessed by QoR-40 Questionnaire 24 Hours After Surgery — 187.8; 189.6; 186.8 units on a scale